Replies to post #6669 on Real Stock Plays

[fast.money]

PLPL News ~ Plandai Biotechnology, Inc. Expands Global Distribution Of Phytofare™ Extracts With Agreement For European Markets

Willows Ingredients to distribute to targeted medical, nutraceutical and animal sectors

Plandai Biotechnology, Inc. (PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced an agreement under which Willows Ingredients, Ltd. of Ireland will distribute Plandai's Phytofare™ extracts into European markets.

Targeted industries included in the agreement are the medical, nutraceutical and animal sectors. Willows Ingredients will have exclusive rights sell and market Phytofare™ to its existing customer base as well as to new customers it adds during the term of the agreement.

Willows Ingredients (www.willowsingredients.ie) is an Irish based, family-owned distributor of raw materials for food, healthcare, sports and animal nutrition industries. The company primarily represents, on an exclusive agreement basis, manufacturers of raw materials used in products for the above markets. Willows works closely with its customers and suppliers on a partnership basis and offers a high level of client service coupled with fast, accurate and reliable responses to both clients and suppliers.

"We continue to focus on securing agreements with highly reputable distributors that have developed extensive clients bases in targeted markets around the world," said Callum Baylis-Duffield, Vice-President and Global Director, Marketing Sales for Plandai Biotechnology. "Agreements like the one with Willows Ingredients will ensure that as we expand production of our Phytofare™ extracts, we will have robust distribution channels already in place in order to achieve corresponding sales growth."

David Scrivens, Managing Director of Willows Ingredients, stated: "We are very excited to have entered into partnership with Phyto Nutricare to market and sell the Phytofare™ range of products in Europe. We feel the Phytofare™ range will be excellent products both for our existing customers and potential new customers and fit perfectly as part of our continued expansion across the European Health & Supplement areas."

In published USDA studies, Plandai's proprietary plant extracts, including Phytofare™ Catechin, Bioflavonoid and Limonoid Glucoside Complex, and Carotenoid botanical extracts, have shown to have improved bioavailability – the degree to which a substance becomes available to the target tissue after administration – of between 60-80%, far exceeding anything available today. Superior levels of bioavailability simply mean that the body can actually receive the benefits promised on the product label.

The Company believes that its technology is the foundation for creating an entirely new family of drugs that can treat a multitude of diseases and conditions safely and affordably using naturally-derived extracts.